The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer – a systematic review
- 1 September 2002
- journal article
- review article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 64 (3) , 239-250
- https://doi.org/10.1016/s0167-8140(02)00184-6
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Update of toxicity following 3D radiation therapy for prostate cancer on RTOG 9406International Journal of Radiation Oncology*Biology*Physics, 2000
- Radical radiotherapy of localised prostate cancer: the relationship between radiation dose and survivalCancer/Radiothérapie, 1998
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Three-dimensional conformal radiotherapy and dose escalation: Where do we stand?Seminars in Radiation Oncology, 1998
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation studyInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Prostate specific antigen levels during radical radiation therapy and the prediction of outcome in localized carcinoma of the prostateClinical Oncology, 1997
- Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effectInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Clinical and Biochemical Evidence of Control of Prostate Cancer at 5 Years After External Beam RadiationJournal of Urology, 1995
- Conformal radiotherapy of the pelvis: assessment of acute toxicityRadiotherapy and Oncology, 1993